Nichd: r & d: androgenic, anabolic, and preclinical safety studies: non-severable
Ended Awarded Last action
- Contract number
- 75N94025F00006
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Obligated
- $49,150
Award facts
- Contract value 7% obligated
-
- $49,150.11 Current, with exercised options
- $748,848.42 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Menlo Park, CA 94025, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $49,150 |
About this award
Sri International, a non-profit research and development organization headquartered in Menlo Park, California, received a $748,848 delivery order from the National Institute of Child Health and Human Development (NICHD) for research and development work on androgenic, anabolic, and preclinical safety studies on a non-severable basis. The contract, awarded on August 1, 2025, operates under a cost-plus-fixed-fee pricing model with an ultimate completion date of July 31, 2029. The work will be performed at Sri International's Menlo Park, California facility. This delivery order was not set aside for small businesses, consistent with Sri International's status as an established large research organization with extensive experience delivering complex research initiatives across federal agencies.
The contract aligns with NICHD's mission to advance research in child health, development, and reproductive sciences. Sri International's deep expertise in biomedical research, demonstrated through its existing Indefinite Delivery Vehicles with the National Institutes of Health that focus on interventional agent development, safety evaluation, and toxicology studies, positions the organization well to conduct the preclinical safety assessments and androgenic-anabolic research required under this effort. The non-severable nature of the work indicates the research components are interdependent and must be completed as an integrated effort over the four-year performance period.
Quick answers
Who was awarded contract 75N94025F00006?
75N94025F00006 was awarded to Sri International by National Institute of Child Health and Human Development (National Institutes of Health) on August 1, 2025.
How much is contract 75N94025F00006 worth?
The government has obligated $49,150 on 75N94025F00006. Its potential value, with all options, is $748,848.
Is contract 75N94025F00006 an order under another contract?
Yes. 75N94025F00006 is a delivery order under 75N94020D00003, an indefinite delivery contract.
Was contract 75N94025F00006 competed?
The extent of competition for 75N94025F00006 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award